Results 211 to 220 of about 315,177 (310)

Flexible Phase Change Bandage Incorporated With Zeolite for Temperature‐Controlled Wound Hemostasis

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
A novel flexible hemostatic phase change bandage (HPB) was designed and constructed through chemical cross‐linking and electrospinning to mitigate thermal injury and broaden the application of PCMs in the medical field. Furthermore, the flexible HPB shows thermal stability, strong mechanical strength, excellent infiltration, and reliable thermal ...
Xinyu Zhang, Keyan Sun, Hanqing Liu, Shihui Zhang, Yan Kou, Haocheng Fu, Zicheng Lu, Yongfei Zhao, Quan Shi   +8 more
wiley   +1 more source

Anticoagulation and the risk of central retinal artery occlusion in post-COVID rhino-orbital-cerebral mucormycosis. [PDF]

Indian J Ophthalmol
Nagarajan S, Ramesh PV, Ramalingam T, Azad A, Aradhya AK.   +4 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Anticoagulants beyond coagulation: a narrative review of cardiovascular effects. [PDF]

Cardiovasc Res
Aarts A, Ten Cate H, Ten Cate-Hoek AJ.
europepmc   +1 more source

Factors responsible for hepatic artery thrombosis after pediatric liver transplantation. [PDF]

, 1989
Belle, S., Esquivel, C.O., Ferla, G., Kahn, D., Kahn, D., Koneru, B., Makowka, L., Mazzaferro, V., Scantlebury, V.P., Scotti-Foglieni, C.L., Starzl, T.E., Todo, S., Tzakis, A.G.   +12 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

The <i>in vitro</i> anticoagulant effect of abelacimab in healthy children. [PDF]

Res Pract Thromb Haemost
Letunica N, Collett S, Karlaftis V, Khder Y, Freedholm D, Monagle P, Attard C.   +6 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source